ALLMedicine™ Aphthous Ulcers Center
Research & Reviews 122 results
Oral Diseases; Tohidinik HR, Rodríguez A et. al.
Jul 10th, 2021 - Recurrent aphthous stomatitis (RAS) is a condition that affects 20% of the world population and is characterized by painful ulcers in the oral mucosa. So far, the epidemiology and risk factors of RAS have been infrequently studied. Our objective w...
Journal of Pediatric Hematology/oncology; Ilonze C, Galipp KM et. al.
Jul 6th, 2021 - Cyclic neutropenia has been rarely associated with chronic inflammation and development of reactive AA amyloidosis. We report a family with cyclic neutropenia with associated renal and thyroid amyloid. A 12-year-old female presented with thyromega...
Neurology Mo A, Donatelli S et. al.
May 28th, 2021 - Child Neurology: Recurrent Brainstem Strokes and Aphthous Ulcers in a Child With Mutations in the ADA2 Gene.|2021|Mo A,Donatelli S,Benson LA,Lee PY,Rivkin MJ,|
BMJ Case Reports; Warrier A, Sruthi M et. al.
May 15th, 2021 - Recurrent aphthous ulcers are the most prevalent oral mucosal disease, but the subset major aphthous ulcer is a less frequent type. These ulcers are refractory, may persist for several weeks to months, and interfere with the normal state of health...
Liver International : Official Journal of the Internation... Deshayes S, Bazille C et. al.
May 10th, 2021 - Secondary to tumour necrosis factor-alpha induced protein 3 (TNFAIP3) mutations, A20 haploinsufficiency (HA20) is a recently described autoinflammatory disease with clinical features similar to those of Behçet's and Crohn's diseases but with a con...
Drugs 1 results see all →
Clinicaltrials.gov 2 results
Jun 20th, 2012 - Recurrent aphthous stomatitis (RAS) is the most painful oral lesion with a considerable prevalence . The most common aphthous ulcer treatments include applying topical agents such as antibiotics, Non Steroidal Anti Inflammatory Drugs (NSAIDs) to i...
Apr 3rd, 2012 - Aphthous ulcers of the mouth or esophagus can interfere with eating, resulting in malnutrition and wasting. Thalidomide has been proposed as an effective therapy for severe forms of aphthous ulceration in AIDS patients. Patients are randomized to ...
News 21 results
Mar 30th, 2021 - The European Commission (EC) has granted marketing clearance for risdiplam (Evrysdi, PTC Therapeutics), the first oral treatment for patients with certain types of spinal muscular atrophy (SMA). Risdiplam is indicated for the treatment of 5q SMA i...
Nov 22nd, 2017 - Chronic, benign familial neutropenia is suggested by a history of long-standing neutropenia without an increased risk for infection. These patients do not generate increased leukocyte counts with infection, but they have fevers and other symptoms,...
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the clinical trials that supported the FDA approval of this drug, and whether there were differences among sex, race, and age groups. The “MORE INFO” b...
Dec 22nd, 2015 - 3. A 58-year-old man sought care for painful sores that had been in his mouth, on and off, for a year.
May 5th, 2015 - The investigators designed the study to shed some light on AGUs, as the available literature is limited, and many providers may not be familiar with the evaluation and management of patients with AGUs, they said. The findings demonstrate that AGUs.